Timmis A D, Fowler M B, Chamberlain D A
Br Med J (Clin Res Ed). 1981 Jan 3;282(6257):7-9. doi: 10.1136/bmj.282.6257.7.
Twelve patients with severe persistent cardiogenic shock complicating acute myocardial infarction underwent single crossover treatment with intravenous dopamine and salbutamol to determine the more beneficial therapy. Salbutamol (10 to 40 microgram/min) reduced systemic vascular resistance and progressively increased both cardiac index and stroke index. Heart rate increased from 95 to 104 beats/min. Changes in mean arterial pressure and pulmonary artery end-diastolic pressure were small and insignificant. Dopamine infusion at rates of 200 and 400 micrograms/min also increased cardiac index and stroke index. Systemic vascular resistance fell slightly but mean arterial pressure rose from 57 to 65 mm Hg. Heart rate increased from 95 to 105 beats/min. Changes in pulmonary artery end-diastolic pressure were again small and insignificant. Dopamine infusion at 800 micrograms/min caused an appreciable increase in systemic vascular resistance; a further increment in mean arterial pressure was observed, though cardiac index fell slightly. Heart rate and pulmonary artery end-diastolic pressure rose steeply. Salbutamol, a vasodilator, increased cardiac output in patients with cardiogenic shock complicating acute myocardial infarction but did not influence blood pressure. If correction of hypotension is essential dopamine in low doses may be the preferred agent. Doses of 800 microgram/min, which is within the therapeutic range, worsen other manifestations of left ventricular dysfunction.
12例急性心肌梗死并发严重持续性心源性休克的患者接受了静脉注射多巴胺和沙丁胺醇的单交叉治疗,以确定哪种治疗更有益。沙丁胺醇(10至40微克/分钟)降低了全身血管阻力,并逐渐增加了心脏指数和每搏指数。心率从95次/分钟增加到104次/分钟。平均动脉压和肺动脉舒张末期压力的变化很小且无统计学意义。以200和400微克/分钟的速率输注多巴胺也增加了心脏指数和每搏指数。全身血管阻力略有下降,但平均动脉压从57毫米汞柱升至65毫米汞柱。心率从95次/分钟增加到105次/分钟。肺动脉舒张末期压力的变化同样很小且无统计学意义。以800微克/分钟的速率输注多巴胺导致全身血管阻力明显增加;观察到平均动脉压进一步升高,尽管心脏指数略有下降。心率和肺动脉舒张末期压力急剧上升。沙丁胺醇作为一种血管扩张剂,可增加急性心肌梗死并发心源性休克患者的心输出量,但不影响血压。如果纠正低血压至关重要,低剂量多巴胺可能是首选药物。800微克/分钟的剂量在治疗范围内,但会加重左心室功能障碍的其他表现。